Byetta, Victoza, May Increase Risk of Dehydration In Diabetes Patients
A new study's findings suggest that Byetta and Victoza can increase the chances of diabetics suffering dehydration.
A new study's findings suggest that Byetta and Victoza can increase the chances of diabetics suffering dehydration.
A federal judge has rejected a call for access to source data on adverse event reports tied to some diabetes drugs and pancreatic cancer, saying it would lead to the…
Following a status conference, deadlines for discovery have been established in the pancreatic cancer lawsuits.
Competing trial plan proposals have been submitted regarding the litigation of pancreatic cancer cases for Byetta, Januvia and Victoza.
The FDA is investigating potential links between the diabetes drug Onglyza and heart failure, following a study late last year.
Two Science Days will be held this week to discuss the science behind Byetta and similar diabetes drugs and their purported links to pancreatic cancer.
A conference today regarding pancreatic cancer lawsuits involving Byetta, Januvia and similar diabetes drugs will tackle key issues regarding the litigation.